Skip to main content
TipRanks
Go Ultimate75% OFF

Sutro Biopharma (STRO) Stock Forecast & Price Target

766 Followers
See the Price Targets and Ratings of:

STRO Analyst Ratings

Strong Buy
4Ratings
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Sutro Biopharma in the past 3 months

STRO Stock 12 Month Forecast

$45.25▲(385.52% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $45.25 with a high forecast of $57.00 and a low forecast of $25.00. The average price target represents a 385.52% change from the last price of $9.32.
Highest Price Target$57.00Average Price Target$45.25Lowest Price Target$25.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for STRO
Price TargetArticle
Wells Fargo$49buy425.75%UpsideAssigned11/16/26
Barclays$56→$57buy511.59%UpsideReiterated11/13/26
Wedbush$60→$25buy168.24%UpsideReiterated11/13/26
H.C. Wainwright$50buy436.48%UpsideReiterated11/13/26
Stifel Nicolaus$48buy415.02%UpsideReiterated08/17/26
Bank of America Securities―sell―Reiterated08/14/26
Truist Financial$50buy436.48%UpsideReiterated08/13/26
LifeSci Capital$54buy479.40%UpsideReiterated08/12/26
TD Cowen―buy―Reiterated08/12/26
Leerink Partners$38→$43buy361.37%UpsideAssigned05/15/26
Mizuho Securities$50buy436.48%UpsideInitiated04/30/26
Citizens JMP$35→$41buy339.91%UpsideReiterated04/23/26
Deutsche Bank $51→$55buy490.13%UpsideReiterated03/25/26
Piper Sandler$20buy114.59%UpsideReiterated12/04/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sutro Biopharma

3 Months
Reni Benjamin
Reni BenjaminCitizens JMP
Success Rate14/36 ratings generated profit
39%
Average Return
-8.58%

Copying Reni Benjamin's trades and holding each position for 3 Months would result in 38.89% of your transactions generating a profit, with an average return of -8.58% per trade.

1 Year
Edward Tenthoff
Edward TenthoffPiper Sandler
Success Rate6/16 ratings generated profit
38%
Average Return
-9.28%

Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -9.28% per trade.

2 Years
Tazeen Ahmad
Tazeen AhmadBank of America Securities
Success Rate4/11 ratings generated profit
36%
Average Return
-9.17%

Copying Tazeen Ahmad's trades and holding each position for 2 Years would result in 36.36% of your transactions generating a profit, with an average return of -9.17% per trade.

STRO Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for STRO
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy8991411
Buy52210
Hold00000
Sell11110
Strong Sell00000
total1412121611

In the current month, STRO has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. STRO average Analyst price target in the past 3 months is 45.25.

STRO Financial Forecast

$-7$-5$-3$-1$1Q1 2026Q3 2026Q4 2026
High$0.45
Consensus$-1.45
Low$-2.36

STRO Earnings Forecast

Next quarter’s earnings estimate for STRO is -$1.45 with a range of -$2.36 to $0.45. The previous quarter’s EPS was -$1.90. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$2M$14M$26M$38M$50MQ1 2026Q3 2026Q4 2026
High$50M
Consensus$14.2M
Low$2M

STRO Sales Forecast

Next quarter’s sales forecast for STRO is $14.17M with a range of $2.00M to $50.00M. The previous quarter’s sales results were $9.10M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

STRO Stock Forecast FAQ

What is STRO’s average 12-month price target, according to analysts?
Based on analyst ratings, Sutro Biopharma’s 12-month average price target is $45.25.
What is STRO’s upside potential, based on the analysts’ average price target?
Sutro Biopharma has 385.52% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is STRO a Buy, Sell or Hold?
Sutro Biopharma has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sutro Biopharma’s price target?
The average price target for Sutro Biopharma is $45.25. This is based on 4 12-month price targets, issued in the past 3 months. The highest analyst price target is $57.00, the lowest forecast is $25.00. The average price target represents a 385.52% increase from the current price of $9.32.
What do analysts say about Sutro Biopharma?
Sutro Biopharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of STRO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.